XML 21 R11.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Cash, Cash Equivalents, and Investments | 3 Months Ended
--- | ---
Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Cash, Cash Equivalents, and Investments | Cash, Cash Equivalents, and Investments Cash, cash equivalents, and investments consisted of the following:
| As of April 30, 2024 |  | As of January 31, 2024
| (in thousands)
Cash and cash equivalents |  |  |
Cash | $ | 50,282 |  |  | $ | 55,736 |
Money market funds | 325,781 |  |  | 305,283 |
Commercial paper | 5,480 |  |  | 994 |
U.S. Treasury securities | 998 |  |  | 998 |
Total cash and cash equivalents | $ | 382,541 |  |  | $ | 363,011 |
Available-for-sale investments: |  |  |
U.S. Treasury securities | $ | 56,683 |  |  | $ | 50,036 |
Commercial paper | 17,102 |  |  | 2,886 |
Corporate debt securities | 108,484 |  |  | 131,259 |
U.S. Government agency securities | 27,973 |  |  | 23,997 |
Total available-for-sale investments | $ | 210,242 |  |  | $ | 208,178 |
The following tables summarize the Company’s investments’ adjusted cost, net unrealized gains (losses), and fair value by significant investment category as of April 30, 2024 and January 31, 2024. Gross realized gains or losses from sales of available-for-sale securities were not material for the three months ended April 30, 2024 and 2023.
| As of April 30, 2024
| Cost Basis |  | Unrealized Loss, Net |  | Estimated Fair Value
| (in thousands)
Available-for-sale investments: |  |  |  |  |
U.S. Treasury securities | $ | 56,750 |  |  | $ | (67) |  |  | $ | 56,683 |
Commercial paper | 17,128 |  |  | (26) |  |  | 17,102 |
Corporate debt securities | 108,958 |  |  | (474) |  |  | 108,484 |
U.S. Government agency securities | 28,069 |  |  | (96) |  |  | 27,973 |
Total available-for-sale investments | $ | 210,905 |  |  | $ | (663) |  |  | $ | 210,242 |
| As of January 31, 2024
| Cost Basis |  | Unrealized Gain (Loss), Net |  | Estimated Fair Value
| (in thousands)
Available-for-sale investments: |  |  |  |  |
U.S. Treasury securities | $ | 50,012 |  |  | $ | 24 |  |  | $ | 50,036 |
Commercial paper | 2,887 |  |  | (1) |  |  | 2,886 |
Corporate debt securities | 131,395 |  |  | (136) |  |  | 131,259 |
U.S. Government agency securities | 23,983 |  |  | 14 |  |  | 23,997 |
Total available-for-sale investments | $ | 208,277 |  |  | $ | (99) |  |  | $ | 208,178 |
The following tables present the Company’s available-for-sale securities by contractual maturity date as of April 30, 2024 and January 31, 2024:
| As of April 30, 2024
| Cost Basis |  | Fair Value
| (in thousands)
Due within one year | $ | 168,837 |  |  | $ | 168,389 |
Due between one to five years | 42,068 |  |  | 41,853 |
Total | $ | 210,905 |  |  | $ | 210,242 |
| As of January 31, 2024
| Cost Basis |  | Fair Value
| (in thousands)
Due within one year | $ | 155,423 |  |  | $ | 155,158 |
Due between one to five years | 52,854 |  |  | 53,020 |
Total | $ | 208,277 |  |  | $ | 208,178 |
As of April 30, 2024, there were 109 securities in an unrealized loss position with an aggregate fair value of $204.8 million, of which 30 were in a continuous unrealized loss position for more than 12 months. The total unrealized loss related to the 30 securities was $0.1 million. As of January 31, 2024, there were 70 securities in an unrealized loss position with an aggregate fair value of $108.7 million, 33 of which were in a continuous unrealized loss position for more than 12 months. The unrealized loss related to the 33 securities was $0.2 million. When evaluating investments for impairment, the Company reviews factors such as the extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company’s intent to sell, or whether it is more likely than not that the Company will be required to sell, the investment before recovery of the investment’s amortized cost. No impairment loss has been recorded on the securities included in the tables above, as the Company believes that any decrease in fair value of these securities is temporary and the Company expects to recover at least up to the initial cost of the investment for these securities. The Company has not recorded an allowance for credit losses, as the Company believes any such losses would be immaterial based on the high-grade credit rating for each of its marketable securities as of the end of each period.

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration